EDITORIAL
Published on 02 Sep 2025
Editorial: PARP inhibitors resistance: new insights in ovarian cancer therapy
doi 10.3389/fonc.2025.1680969
- 784 views
- Frontiers in Oncology
- Gynecological Oncology
- Research Topics
- PARP inhibitors resistance: new insights in ovarian cancer therapy
PARP inhibitors resistance: new insights in ovarian cancer therapy
5,352
Total downloads
19k
Total views and downloads
Articles
REVIEW
Published on 29 Jul 2024
Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer
doi 10.3389/fonc.2024.1414112
- 3,173 views
- 5 citations
ORIGINAL RESEARCH
Published on 27 Jun 2024
Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance
doi 10.3389/fonc.2024.1402851
- 3,096 views
- 6 citations
ORIGINAL RESEARCH
Published on 25 Apr 2024
RAD51 as an immunohistochemistry-based marker of poly(ADP-ribose) polymerase inhibitor resistance in ovarian cancer
doi 10.3389/fonc.2024.1351778
- 2,680 views
- 5 citations
REVIEW
Published on 13 Mar 2024
BRCA1/2 alterations and reversion mutations in the area of PARP inhibitors in high grade ovarian cancer: state of the art and forthcoming challenges
doi 10.3389/fonc.2024.1354427
- 5,880 views
- 21 citations
